
# Hidden Influencer Conduits

**Hypothesis ID:** bf55e8baaacf224459004e9f9e9135aa32f6d2f24c2b5f5fd6f9f982a5f406ac

**Subgraph ID:** 55d93cbcc225b166084d73d8e71f3ef21aeac51804532a5f9b698fcde97a33f7

The subgraphâ€™s structure hints at a group of nodes that are not immediately apparent as central yet maintain multiple high-impact pathways across seemingly disparate clusters. Their intermediary positions within various paths suggest these nodes may serve as critical conduits for information or resources, subtly influencing broader network behavior. Investigating these nodes further could uncover non-obvious causal links that explain emergent dynamics in the system.

2.

## References


## Context
None

## Subgraph
```
(Autoimmunity)-[:`is associated with a dysregulation in the`]->(`Th17 cell pathway`),
(`Th17 cell pathway`)-[:`is modulated by the cytokine`]->(`Interleukin-23 (IL-23)`),
(`Interleukin-23 (IL-23)`)-[:`stimulates the production of`]->(`Matrix metalloproteinases (MMPs)`),
(`Matrix metalloproteinases (MMPs)`)-[:`are involved in the degradation of`]->(`extracellular matrix components`),
(`extracellular matrix components`)-[:`play a role in the recruitment of`]->(`fibroblast-like synoviocytes (FLS)`),
(`fibroblast-like synoviocytes (FLS)`)-[:`contribute to the expression of`]->(`pro-inflammatory cytokines`),
(`pro-inflammatory cytokines`)-[:`activate signaling pathways leading to`]->(`osteoclast differentiation`),
(`osteoclast differentiation`)-[:`leads to increased resorption of`]->(`bone tissue`),
(`bone tissue`)-[:`undergoes remodeling mediated by`]->(`RANK/RANKL pathway`),
(`RANK/RANKL pathway`)-[:`is inhibited by the administration of`]->(Denosumab),
(Denosumab)-[:`reduces the incidence of`]->(`osteoporotic fractures in patients with rheumatoid arthritis`),
(`osteoporotic fractures in patients with rheumatoid arthritis`)-[:`are characterized by a reduction in`]->(`bone mineral density (BMD)`),
(`Interleukin-23 (IL-23)`)-[:`promotes the activity of`]->(`fibroblast-like synoviocytes (FLS)`),
(`Matrix metalloproteinases (MMPs)`)-[:`facilitate the turnover of`]->(`bone tissue`),
(`osteoclast differentiation`)-[:`is potentiated by the`]->(`Th17 cell pathway`),
(`bone tissue`)-[:`is structurally supported by`]->(`extracellular matrix components`),
(`pro-inflammatory cytokines`)-[:`are elevated in conditions of`]->(`low bone mineral density (BMD)`),
(`bone mineral density (BMD)`)-[:`is indirectly maintained by the presence of`]->(`extracellular matrix components`),
(Denosumab)-[:`modulates the production of`]->(`Matrix metalloproteinases (MMPs)`),
(`Th17 cell pathway`)-[:`influences the expression of`]->(`RANK/RANKL pathway`),
(`fibroblast-like synoviocytes (FLS)`)-[:`interact with the`]->(`RANK/RANKL pathway`),
(Autoimmunity)-[:`induces imbalances in`]->(`pro-inflammatory cytokines`)
```
